Fundamentals

Valuation

Metric	Q2	Q4	Δ in %
EV/EBITDA	25.66	-292.67	-393.70
Graham Fair Price	-0.95	6.24	6.30
PEG	-73.45	-1.33	5.00
Price/Book	14.31	7.54	6.60
Price/Cash Flow	-13.13	24.14	27.79
Prices/Earnings	30.47	11.44	8.77
Price/Sales	6.18	3.58	3.37
Price/FCF	-13.13	24.14	27.79
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q2	Q4	Δ in %
Gross Profit Margin	1.67	1.00	0.98
Operating Margin	-18.14	0.11	0.14
ROA	8.37	0.03	0.03
ROE	0.19	0.16	-12.39
ROIC	0.08	0.09	8.41
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q4	Δ in %
Debt QOQ	-0.05	0.24	-80.23
Dividends QOQ	-0.50	-0.03	94.49
EBIT QOQ	0.68	-0.06	-91.48
EPS QOQ	0.02	-0.09	391.38
FCF QOQ	0.71	0.41	-42.79
Revenue QOQ	1.27	0.15	-88.10
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q2	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.60	0.54	-11.19
Quick Ratio	20.41	-1.57	-92.33
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q2	Q4	Δ in %
Book Value	3.06	3.24	5.82
Cash	10.64	4.44	-58.32
Capex	-0.15	-0.10	34.97
Free Cash Flow	0.73	1.01	39.23
Revenue	6.00	6.83	13.92
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q2	Q4	Δ in %
Current Ratio	20.41	-2.06	-89.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-45.89	-30.10	34.40
Naive Interpretation	Member

06 - Financial Health · Bad

Rating